API

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
231	α1−アンチトリプシン欠乏症	3

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

231. α1−アンチトリプシン欠乏症

臨床試験数 : 93 / 薬物数 : 77 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 36

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-000917-59-SE (EUCTR)	04/08/2016	08/06/2016	A clinical trial to assess the safety and effects of a novel medicine intended for the treatment of ...	An Open-Label, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Effect on Circula ...	Alpha-1 Antitrypsin Deficiency related liver disease MedDRA version: 19.0;Level: PT;Classification c ...	Product Name: ARC-AAT Injection Product Code: ARC-AAT INN or Proposed INN: API-AAT Other descriptive na ...	Arrowhead Pharmaceuticals Inc	NULL	Not Recruiting			Female: yes Male: yes	12	Phase 2	Canada;Ireland;Sweden
2	EUCTR2016-000917-59-IE (EUCTR)	29/06/2016	13/04/2016	A clinical trial to assess the safety and effects of a novel medicine intended for the treatment of ...	An Open-Label, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Effect on Circula ...	Alpha-1 Antitrypsin Deficiency related liver disease MedDRA version: 19.1;Level: PT;Classification c ...	Product Name: ARC-AAT Injection Product Code: ARC-AAT INN or Proposed INN: API-AAT Other descriptive na ...	Arrowhead Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	12	Phase 2	Canada;Ireland;Sweden
3	NCT00460096 (ClinicalTrials.gov)	March 2007	12/4/2007	Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antit ...	Randomized Double-Blind Comparison of an Alpha-1 Proteinase Inhibitor (Kamada API) With a Currently ...	Alpha 1-Antitrypsin Deficiency	Drug: Kamada-API	Kamada, Ltd.	NULL	Completed	18 Years	N/A	Both	50	Phase 2/Phase 3	United States

First Previous1Next Last

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01347190 (ClinicalTrials.gov)	April 2011	3/5/2011	Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fi ...	A Double Blind, Randomized, Placebo Controlled, Single Dose, Phase I Study of the Safety and Tolerab ...	Cystic Fibrosis	Biological: CR002 Liquid API;Biological: Placebo	CSL Behring	NULL	Completed	18 Years	65 Years	Both	25	Phase 1	Bulgaria;Hungary;Poland;United Kingdom

First Previous1Next Last